For musculoskeletal use, it is commonly considered for tendon irritation, ligament sprains, muscle strains, fascia-related pain, overuse injuries, and joint-adjacent soft-tissue pain
## **HCPCS code Q5121 billing requirements** The billing requirements for HCPCS code Q5121 (injection of infliximab-axxq, biosimilar Avsola, 10 mg) include the following key points: - Report HCPCS Q5121 to document the administration of infliximab-axxq in 10 mg units
References: Vukojevic J, Milavi M, Perovi D, et al
We are conveniently located at 8233 Fredericksburg Rd, San Antonio, TX 78229
Its pharmacological interest is as an inhibitor of nicotinamide N-methyltransferase, usually written NNMT